Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

Clinical trial NCT07365423 · RECRUITING

Trial details

NCT number: NCT07365423
Sponsor: Swiss Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Prostate Cancer

Start date: 2026-04-24
Primary completion: 2028-02-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.